Financial statements Namedycyne
Balance sheet data of NAMEDYCYNE
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 219 293,94 | 482 659,83 | 699 798,46 | 983 262,41 |
| A. Fixed assets | - | 0,00 | 10 562,50 | 812,50 |
| B. Current assets | 219 293,94 | 482 659,83 | 689 235,96 | 982 449,91 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 219 396,94 | 482 659,83 | 699 798,46 | 983 262,41 |
| A. Equity | 76 739,35 | 183 075,10 | 354 837,65 | 655 107,40 |
| B. Liabilities and provisions for liabilities | 142 554,59 | 299 584,73 | 344 960,81 | 328 155,01 |
| I. Long-term liabilities | 25 024,66 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 117 529,93 | 299 584,73 | 344 960,81 | 328 155,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.